Pacific Biosciences of California, Inc. Contract Liability (Deferred Revenue)
Pacific Biosciences of California, Inc. (PACB) had Contract Liability (Deferred Revenue) of $16.10 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Contract with Customer, Liability, Current $16.10M.
- 2026-03-31: Contract with Customer, Liability, Current $16.33M.
- 2025-12-31: Contract with Customer, Liability, Current $15.94M.
- 2025-09-30: Contract with Customer, Liability, Current $16.05M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $16.10M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $16.33M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $15.94M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $16.05M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $14.86M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $15.24M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $13.86M 10-K · filed 2026-02-25 |
| 2024-09-30 | $17.29M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $19.21M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $17.35M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $16.34M 10-K · filed 2025-03-17 |
| 2023-09-30 | $22.37M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $24.98M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $30.87M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $30.50M 10-K · filed 2024-02-28 |
| 2022-09-30 | $30.69M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $32.08M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $12.73M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $10.98M 10-K · filed 2023-02-28 |
| 2021-09-30 | $9.77M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $9.53M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $9.61M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.72M 10-K · filed 2022-02-28 |
| 2020-09-30 | $6.98M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $6.93M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $7.11M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $7.61M 10-K · filed 2021-02-26 |
| 2019-09-30 | $6.38M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $6.71M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $6.43M 10-Q · filed 2019-05-03 |
| 2018-12-31 | $6.54M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |